DCVMN Webinar – September 23rd 2021: Standardizing and Streamlining Vaccine Antigen Quantification for Polio, Measles, and Rubella
Mark your Calendar for our webinar on Thursday September 23rd on at (13:00 CET/ 05:00 MST). 2021 for DCVMN members.
Speaker: Dr. Kathy Rowlen
Title: Chief Technology Officer
Bio: Dr. Kathy Rowlen has more than 20 years of management and research experience in business and academics, with more than 10 years in the field of biotechnology. Rowlen was a successful Professor of Chemistry at the University of Colorado in Boulder from 1991 to 2008. After co-founding InDevR in 2003 and serving as its Chief Science Officer, she transitioned to a full-time position as InDevR’s CEO in 2008.
Dr. Rowlen has a well-earned reputation as a resourceful business entrepreneur and has raised substantial non-dilutive funding. Under her leadership, InDevR has demonstrated excellence in translating innovative ideas into high-impact commercial products.